homeostasis/metabolism
• streptozotocin-treated mice do not exhibit the increase in plasma creatinine levels observed in similarly treated wild-type mice
|
• streptozotocin-treated mice do not exhibit the increase in blood urine nitrogen levels observed in similarly treated wild-type mice
|
• streptozotocin-treated mice do not exhibit the increase in kidney weight, plasma creatinine levels, blood urine nitrogen levels, and glomerular basement membrane thickening, reduction in body weight, and mesangial expansion observed in similarly treated wild-type mice
• however, streotozotocin-treated mice exhibit hyperglycemia, albuminuria, and reduced slit pore opening as in wild-type mice
|
renal/urinary system
• streptozotocin-treated mice do not exhibit the increase in glomerular basement membrane thickening observed in similarly treated wild-type mice
|
• streptozotocin-treated mice do not exhibit the mesangial matrix expansion observed in similarly treated wild-type mice
|
• streptozotocin-treated mice do not exhibit the increase in kidney weight observed in similarly treated wild-type mice
|
growth/size/body
• streptozotocin-treated mice do not exhibit the decreased in body weight observed in similarly treated wild-type mice
|